Olmesartan Medoxomil plus Amlodipine Increases Efficacy in Patients with Moderate-to-Severe Hypertension after Monotherapy: A Randomized, Double-Blind, Parallel-Group, Multicentre Study

By Barrios Vivencio  

Clinical Drug Investigation, Vol. 29, Iss. 7, 2009-06 ,pp. : 427-439

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Olmesartan Medoxomil Combined with Amlodipine in Patients with Moderate to Severe Hypertension after Amlodipine Monotherapy: A Randomized, Double-Blind, Parallel-Group, Multicentre Study

By Volpe Massimo  

Clinical Drug Investigation, Vol. 29, Iss. 1, 2009-01 ,pp. : 11-25

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension: A Randomized, Double-Blind, Parallel-Group, Multicentre, Multinational, Phase III Study

By Fogari Roberto  

Clinical Drug Investigation, Vol. 30, Iss. 9, 2010-09 ,pp. : 581-597

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Olmesartan Medoxomil and Hydrochlorothiazide Compared with Benazepril and Amlodipine Besylate

By Kereiakes Dean J.  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 5, 2007-01 ,pp. : 361-372

Adis International

Access to resources Recommend Favorite

Long-Term Safety and Tolerability of the Oral Direct Renin Inhibitor Aliskiren with Optional Add-On Hydrochlorothiazide in Patients with Hypertension: A Randomized, Open-Label, Parallel-Group, Multicentre, Dose-Escalation Study with an Extension Phase

By Sica Domenic  

Clinical Drug Investigation, Vol. 31, Iss. 12, 2011-12 ,pp. : 825-837

Adis International

Access to resources Recommend Favorite